Previous close | 56.64 |
Open | 57.65 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 57.33 - 57.84 |
52-week range | 34.19 - 66.00 |
Volume | |
Avg. volume | 96,301 |
Market cap | 41.402B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 59.19 |
EPS (TTM) | 0.97 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 0.39 (0.68%) |
Ex-dividend date | 09 May 2023 |
1y target est | 66.20 |
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...
Key Insights The considerable ownership by individual investors in Lonza Group indicates that they collectively have a...